This investigation was undertaken in view of the interest lately aroused in the association of plasma lipids with atherosclerosis. Observations on the antilipemic and anticoagulant activities in man of sodium polyethylene sulfonate, a new drug with heparin-like properties, are presented. Alteration of the serum lipoprotein patterns of these patients observed during the course of the drug administration is also described.